Alyeska Investment Group
CYTK icon

Alyeska Investment Group’s Cytokinetics CYTK Stock Holding History

Alyeska Investment Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3M Buy
250,000
+100,000
+67% +$7.18M 0.05% 328
2026
Q1 		$9.89M Buy
+150,000
New +$9.53M 0.03% 400
2025
Q2 		– Sell
-75,000
Closed -$3.01M – 590
2025
Q1 		$3.01M Sell
75,000
-75,000
-50% -$3.45M 0.01% 396
2024
Q4 		$7.06M Buy
150,000
+125,000
+500% +$6.49M 0.03% 378
2024
Q3 		$1.32M Buy
+25,000
New +$1.39M 0.01% 445
2015
Q4 		– Sell
-40,485
Closed -$271K – 403
2015
Q3 		$271K Hold
40,485
– – ﹤0.01% 442
2015
Q2 		$272K Hold
40,485
– – ﹤0.01% 471
2015
Q1 		$274K Buy
40,485
+13,158
+48% +$98.3K ﹤0.01% 482
2014
Q4 		$219K Sell
27,327
-3,554
-12% -$15.3K ﹤0.01% 465
2014
Q3 		$109K Sell
30,881
-3,532
-10% -$14.8K ﹤0.01% 376
2014
Q2 		$164K Sell
34,413
-228,155
-87% -$1.39M ﹤0.01% 391
2014
Q1 		$2.49M Sell
262,568
-68,463
-21% -$619K 0.07% 251
2013
Q4 		$2.15M Hold
331,031
– – 0.09% 224
2013
Q3 		$2.51M Buy
331,031
+150,321
+83% +$1.61M 0.1% 207
2013
Q2 		$2.09M Buy
+180,710
New +$1.42M 0.1% 193

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alyeska Investment Group's CYTK Position: Q2 2026 in Review

Alyeska Investment Group increased its Cytokinetics (CYTK) stake by 67% in Q2 2026, buying an estimated $7.18M and bringing the position to 250,000 shares worth $21.3M. The position accounts for 0.05% of the portfolio, ranked #328.

Alyeska Investment Group first reported a position in CYTK in Q2 2013 and has held it in 15 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Alyeska Investment Group held 250,000 shares of Cytokinetics worth $21.3M as of Q2 2026.
  • Alyeska Investment Group bought 100,000 Cytokinetics shares in Q2 2026, an estimated $7.18M.
  • Cytokinetics made up 0.05% of Alyeska Investment Group's portfolio in Q2 2026, its #328 holding.
  • Alyeska Investment Group first reported a position in Cytokinetics in Q2 2013 and has held it in 15 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.